Lexaria Bioscience Corp.

Lexaria Bioscience Corp.verified

LEXX

Price:

$0.6145

Market Cap:

$12.56M

Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of active pharmaceutical ingredients, enhancing their absorption into the bloodstream. This innovative platform has shown impressive results, boosting the bioavailability of compounds such as cannabinoids and nicotine by 5 to 10 times, and in some cannabinoid applications, by as much as 27 times, when compared to standard formulations. DehydraTECH also drastically cuts the time of onset from hours to mere minutes and effectively neutralizes unpleasant tastes. Beyond its established uses, the technolog...[Read more]

Industry

Biotechnology

IPO Date

2021-01-12

Stock Exchange

NASDAQ

Ticker

LEXX

The Enterprise Value as of June 2026 (TTM) for Lexaria Bioscience Corp. (LEXX) is 7.53M

According to Lexaria Bioscience Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.53M. This represents a change of -50.01% compared to the average of 15.06M of the last 4 quarters.

Lexaria Bioscience Corp. (LEXX) Historical Enterprise Value (quarterly & annually)

How has LEXX Enterprise Value performed in the past?

The mean historical Enterprise Value of Lexaria Bioscience Corp. over the last ten years is 13.34M. The current 7.53M Enterprise Value has changed 5.54% with respect to the historical average. Over the past ten years (40 quarters), LEXX's Enterprise Value was at its highest in in the May 2024 quarter at 45.58M. The Enterprise Value was at its lowest in in the May 2023 quarter at 1.80M.

Quarterly (TTM)
Annual

Average

13.34M

Median

10.81M

Minimum

5.76M

Maximum

42.06M

Lexaria Bioscience Corp. (LEXX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Lexaria Bioscience Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 630.61%

Maximum Annual Enterprise Value = 42.06M

Minimum Annual Increase = -66.35%

Minimum Annual Enterprise Value = 5.76M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202514.15M-66.35%
202442.06M630.61%
20235.76M-50.62%
202211.66M-29.33%
202116.49M46.13%
202011.29M9.25%
201910.33M16.38%
20188.88M41.25%
20176.28M-3.28%
20166.50M14.64%

Lexaria Bioscience Corp. (LEXX) Average Enterprise Value

How has LEXX Enterprise Value performed in the past?

The current Enterprise Value of Lexaria Bioscience Corp. (LEXX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

20.66M

5-year avg

18.02M

10-year avg

13.34M

Lexaria Bioscience Corp. (LEXX) Enterprise Value vs. Peers

How is LEXX’s Enterprise Value compared to its peers?

Lexaria Bioscience Corp.’s Enterprise Value is less than Hoth Therapeutics, Inc. (20.84M), less than Allarity Therapeutics, Inc. (24.44M), less than Lixte Biotechnology Holdings, Inc. (69.65M), less than Entero Therapeutics, Inc. (19.92M), less than Clearside Biomedical, Inc. (56.30M), less than Cingulate Inc. (8.89M), greater than BriaCell Therapeutics Corp. (-1763599.79), less than CASI Pharmaceuticals, Inc. (18.28M), greater than Processa Pharmaceuticals, Inc. (3.23M), greater than Curis, Inc. (-8118049.00),

Build a custom stock screener for Lexaria Bioscience Corp. (LEXX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lexaria Bioscience Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lexaria Bioscience Corp. (LEXX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lexaria Bioscience Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Lexaria Bioscience Corp.'s Enterprise Value?

What is the highest Enterprise Value for Lexaria Bioscience Corp. (LEXX)?

What is the 3-year average Enterprise Value for Lexaria Bioscience Corp. (LEXX)?

What is the 5-year average Enterprise Value for Lexaria Bioscience Corp. (LEXX)?

How does the current Enterprise Value for Lexaria Bioscience Corp. (LEXX) compare to its historical average?